Therapeutic potential of plant-derived amiRNAs: challenges and strategies
ExRNA · 2024
DOI: 10.55092/exrna20240003 ↗Kurz gefasst
Fachartikel in der Zeitschrift ExRNA, 2024. Verfasst von Xuanlin Li und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Small RNAs (sRNAs) are potent and accurate genetic regulators capable of targeting a diverse range of genes in eukaryotes. In recent years, the sRNA-based RNA interference (RNAi) technique has emerged as a promising strategy for modifying pathological processes by targeting specific genes or gene families, thereby promoting RNAi-based precise medical therapy. Notably, plant-derived miRNAs have shown promise in the treatment of various disorders, including cancer, neurodegenerative diseases, and infectious diseases. This review examines the therapeutic potential of plant-derived natural miRNAs and artificial miRNAs (amiRNAs), especially sourced from edible plants like crops and herbs. In addition, we discuss the challenges and strategies of utilizing amiRNAs in the therapeutic application and highlight the essential factors for effectively producing desired miRNA mimics in plants.
Zitieren
APA
Li, X., Wang, Y., & Hong, Z. (2024). Therapeutic potential of plant-derived amiRNAs: challenges and strategies. ExRNA. https://doi.org/10.55092/exrna20240003
Vancouver
Li X, Wang Y, Hong Z. Therapeutic potential of plant-derived amiRNAs: challenges and strategies. ExRNA. 2024. doi:10.55092/exrna20240003
BibTeX
@article{Li2024,
author = {Li, Xuanlin and Wang, Yuan and Hong, Zhi},
title = {Therapeutic potential of plant-derived amiRNAs: challenges and strategies},
journal = {ExRNA},
year = {2024},
doi = {10.55092/exrna20240003}
}
EUVIMED